supp.ai
Discover Supplement-Drug Interactions
Disclaimer: The information contained herein should NOT be used as a substitute for the advice of an appropriately qualified and licensed physician or other health care provider. The tool is not a substitute for the care provided… (more)
Last Updated: 3 years ago
supplement:
3-Nitrotyrosine
drug:
Olmesartan
Research Papers that Mention the Interaction
“In addition, olmesartan treatment significantly lowered the protein expressions ( Nitrotyrosine , p47phox and p67phox) and superoxide radical production compared with those of vehicle-treated DCM rats.”
Olmesartan medoxomil treatment potently improves cardiac myosin-induced dilated cardiomyopathy via the modulation of ACE-2 and ANG 1–7 mas receptor“Myocardial protein expressions of AT1R, NADPH oxidase subunits (p47phox, p67phox, gp91phox) and the expression of markers of oxidative stress 3-nitrotyrosine and 4-hydroxy-2-nonenal), and the cardiac apoptosis were also significantly decreased by the treatment with olmesartan compared with those of vehicle-treated rats.”
Help us improve supp.ai, we'd love to hear your feedback: Submit Feedback